Mammalian hosts coordinate various cell death pathways as part of the immune defense system against pathogens including ...

Indeed, the pathogen seems like ancient history — but as recent developments indicate, tuberculosis isn’t done with us yet.

According to the Global TB Report by WHO, India has seen a decline of 16 per cent in TB incidence (new cases emerging each ...

Tuberculosis (TB) is a serious infectious disease caused by the bacterium Mycobacterium tuberculosis. While multidrug treatment regimens are the standard of care, the lengthy treatment schedule and ...

Australian researchers have developed a new mRNA vaccine for tuberculosis, showing effective results in mice. The vaccine ...

A new mRNA vaccine against tuberculosis (TB) is showing favorable results in preclinical trials. With only one currently ...

Metaba, LLC ( and MAX BioPharma, Inc. ( are pleased to announce significant progress in their collaboration to develop ...

Römpp, A., Treu, A., Kokesch-Himmelreich, J. et al. The clinical-stage drug BTZ-043 accumulates in murine tuberculosis lesions and efficiently acts against Mycobacterium tuberculosis. Nat Commun 16, ...

David Ussery and Brian Delavan discuss bioinformatics into TB surveillance, presenting a new approach to tackling this ...

Every year, 10 million people contract tuberculosis (TB), a disease caused by the bacterium Mycobacterium tuberculosis (Mtb), and approximately 1.5 million patients succumb to the disease. Treatment ...

CAR in Baguio on February 15, 2024 (Source: PIA website) Tuberculosis (TB) is an infectious disease that most often affects ...

A simple model projected which strains were likely to be highly transmissible, with implications for public health.